RE:Valeant never invested a cent in Groupe CosmodermThat's obvious, as contrast to the aggressive growth measures now in place.
As a large fraction of their sales are OTC, a large sales staff is not necessary.
Instead of visiting 50,000 physicians, they have about most of the market in perhaps 10 or so of the larger Pharma chains.
We should be getting news soon on IMDIS launch